Clinical Trial Update: Risk Stratification in End Stage Renal Disease (ESRD) - ISAR Study

View source ↗

Summary

Clinical trial update on risk stratification in end-stage renal disease from the ISAR study, relating to ESRD/CKD and cardiovascular outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease
• End-stage Renal Disease
• Sudden Cardiac Death

Snippet

Sponsor: Technical University of Munich | Conditions: End Stage Renal Disease, Chronic Kidney Disease | Status: UNKNOWN